We tested the role of interleukin-6 (IL-6) in sepsis-induced muscle proteol
ysis by determining ubiquitin mRNA levels and protein breakdown rates in in
cubated extensor digitorum longus muscles from septic and sham-operated IL-
6 knockout and wild-type mice. In addition, the effect of treatment of mice
with human recombinant IL-6 on muscle protein breakdown rates was determin
ed. Finally, protein breakdown rates were measured in myotubes treated for
up to 48 h with different concentrations of IL-6. Sepsis in wild-type mice
resulted in an approximately ninefold increase in plasma IL-6 levels, where
as IL-6 was not detectable in plasma of sham-operated or septic IL-6 knocko
ut mice. Total and myofibrillar muscle protein breakdown rates were increas
ed by similar to 30% and threefold, respectively, in septic IL-6 wild-type
mice with an almost identical response noted in septic IL-6 knockout mice.
Ubiquitin mRNA levels determined by dot blot analysis were increased during
sepsis in muscles from both IL-6 knockout and wild-type mice, although the
increase was less pronounced in IL-6 knockout than in wild-type mice. Trea
tment of normal mice or of cultured L6 myotubes with IL-6 did not influence
protein breakdown rates. The present results suggest that IL-6 does not re
gulate muscle proteolysis during sepsis.